The current status of research into attention deficit hyperactivity disorder: proceedings of the 2nd international congress on ADHD: from childhood to adult disease Johannes ThomeDuvvoor Prathap Reddy Review Article 17 November 2009 Pages: 165 - 174
Tolerability and effects of OROS® MPH (Concerta®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial Martin GerweKirsten StollhoffSteffen Heger Original Article 06 August 2009 Pages: 175 - 186
Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings Ralf W. DittmannPeter M. WehmeierGerd Lehmkuhl Original Article Open access 23 September 2009 Pages: 187 - 200
Relationship between atomoxetine plasma concentration, treatment response and tolerability in attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder Philip HazellKatja BeckerRalf W. Dittmann Original Article Open access 23 September 2009 Pages: 201 - 210
Delayed sleep phase disorder and Attention deficit and hyperactivity symptoms in a teenager Khurshid A. KhurshidAliya A. Khan Original Article 05 November 2009 Pages: 211 - 213
The Kiddie-SADS allows a dimensional assessment of externalizing symptoms in ADHD children and adolescents Thomas JansPeter WeyersAndreas Warnke Original Article 27 October 2009 Pages: 215 - 222
Maternal smoking during pregnancy and offspring attention-deficit/hyperactivity disorder: a case–control study in Japan Kouichi YoshimasuChikako KiyoharaThe Wakayama ADHD Study Group Original Article 12 November 2009 Pages: 223 - 231